Drugs / ATI355
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00406016 | May 2006 → Sep 2011 | spinal cord injury | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATI355 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00406016 ↗ |
| Route | Intrathecal | “Continuous Intrathecal ATI355 Infusion” NCT00406016 ↗ |